Organ Technology that Ignites Hope.

This Changes Everything.

A young female transplant patient focusing on painting a portrait on canvas in a well-lit indoor studio.

Smiling woman holding a slice of red onion in a vibrant kitchen while preparing vegetables.

Surgical team professional in surgical attire focused under bright operating room lights.

Close-up of hands gently clasped, conveying compassion and human connection.

We’re driven by a commitment to make organ transplants safer, easier and more accessible for people with organ failure.

Our organ technology is enhancing research at some of the world’s top institutions¹ to treat diseased organs and develop technologies that may someday make transplantation the last line in a broader range of treatment options.

We’re driven by a commitment to make organ transplants safer, easier and more accessible for people with organ failure.

Our organ technology is enhancing research at some of the world’s top institutions¹ to treat diseased organs and develop technologies that may someday make transplantation the last line in a broader range of treatment options.

Surgeon wearing magnifying glasses and a surgical mask focused during an operation.

Young woman playing piano alongside an older woman, a transplant patient, in a bright and cozy home setting.

Surgical team performing an organ transplantation procedure under focused lighting in an operating room

Two fishermen on a wooden boat pulling in nets on a calm ocean near a green coastal hill.

Woman smiling warmly in a red jacket with buildings and a clear blue sky in the background, representing the patients and providers who are part of the organ transplant journey

A Novel Liver Support System for Acute-on-Chronic Cases

In 2025, we are beginning the first in-human trial of our extracorporeal liver cross-circulation (ELC) system, co-developed with eGenesis. The trial will use eGenesis’s human-compatible, genetically engineered porcine livers. For patients with acute-on-chronic liver failure, this treatment may provide a bridge to transplant or much-needed time for their native liver to recover.

Learn More

Beyond Liver, Beyond Transplantation

As we continue to develop the transformative potential of NMP technology, we’re looking ahead to take on even greater challenges and develop new technologies that will help save more lives.

OrganOx metra® for Additional Organs

We’re currently working on NMP perfusion products to support additional organs, including kidney, to extend this life saving technology to even more patient populations in the near future.

Microscopic image of simple cuboidal epithelium tissue showing pink-stained cells arranged in tubular structures

NMP for Organ Support & Enhancement

With further development, NMP holds the potential to ultimately help heal organs inside or outside the body. Treating and potentially improving the quality of these organs may eventually enable clinicians to offer alternative therapies to patients for whom transplant is the only current life-saving option.

Smiling person standing in an urban alleyway lined with red brick buildings.

Surgeons and medical staff performing an organ transplant operation in a hospital operating room, all wearing surgical masks and scrubs.

NMP for Drug Exploration

Through partnerships with biopharma manufacturers, we’re exploring new ways for our organ technology to help shorten the time needed to test new drugs for safety and effectiveness. Our platform’s potential to help make drug discovery and development more efficient and cost-effective may ultimately lead to accelerating the development timelines for a broad range of diseases.

Testing drugs on research organs outside the human body could give biopharma researchers valuable information earlier in the drug discovery process. This would enable them to refine therapies and reduce — or perhaps even eliminate — the need for animal testing, thus lowering risks to living human research subjects.

From Our Newsroom

Keep up to date with the latest OrganOx updates and recent news in organ transplantation.

News

Terumo to acquire OrganOx Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related sector

News

OrganOx Announces Second Private Placement Closing, Investments by Intuitive Ventures and Terumo Ventures

Press Release

eGenesis and OrganOx Announce U.S. FDA Clearance of IND Application for the Treatment of Patients with Acute-On-Chronic Liver Failure

Company Data on file

Organ Technology that Ignites Hope.

This Changes Everything.

We’re driven by a commitment to make organ transplants safer, easier and more accessible for people with organ failure.

Our organ technology is enhancing research at some of the world’s top institutions1 to treat diseased organs and develop technologies that may someday make transplantation the last line in a broader range of treatment options.

A Novel Liver Support System for Acute-on-Chronic Cases

Beyond Liver, Beyond Transplantation

From Our Newsroom

Terumo to acquire OrganOx Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related sector

OrganOx Announces Second Private Placement Closing, Investments by Intuitive Ventures and Terumo Ventures

eGenesis and OrganOx Announce U.S. FDA Clearance of IND Application for the Treatment of Patients with Acute-On-Chronic Liver Failure

Our organ technology is enhancing research at some of the world’s top institutions¹ to treat diseased organs and develop technologies that may someday make transplantation the last line in a broader range of treatment options.